Clinear Research Ltd
1) Bureau 562, 59 Rue De Ponthieu, 75008, Paris, France
2) 228 Avenue Souffleur , Flic en Flac , Mauritius
At Clinear Research, our people are inspired by the story of each patient with whom our medical staff have a deep connection
We know how to deal with complex, International and Innovative Clinical Research Studies and our team uses its expertise and values to better connect the dots between the industry, diverse patients and sites across the globe for a healthier world
“We are what we repeatedly do. Excellence then, is not an act, but a habit” —Aristotle
We provide an end-to-end solution tailored to the clinical trial need of the client
Providing Complete Trial Management Services tailored made to your clinical trial need and global expansion
Providing effective support to the Investigators and his collaborators
Trending to a new norm:From on-site to Remote management and monitoring
Helping you remain ahead of the curve by enabling you to understand the current and future trends in your industry
Lutchmee Nobaub completed her higher education at the Paris XII university , in science, health, and application. She has more than 16 years experience in clinical research, accumulating, through different positions, experiences, and contacts throughout Western Europe. After ten years of working for the top 4 CROs, she founded Clinear Research where she managed more than 30 studies in Mauritius, Réunion, Islands, and western Europe.
This adventure allowed her to learn new aspects of her profession, as a business manager, and to diversify her skills. The necessary adaptation to a very different local reality allowed her to find the means to combine international requirements and local specificities and regulations.
Since 2021, she has received several awards including Health Revelation at Women In Africa Initiative, Laureate WIA54 2021 and Africa’s most respected CEO award 2022.
Participating in the progress of medicine and the care of patients particularly the pan-African population has been her main motivation. She strongly believes in a personalized medicine tailored to the patient’ interest and genetic diversity.